Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. paclitaxel/carboplatin/lapatinib

   Hospital Authority, Hong Kong

   ErbB2-Positive Stage I-III Breast Cancer

   phase 2 · small molecule · active

   1 trial →

2. palifosfamide

   Alaunos Therapeutics

   Adult Central Nervous System Germ Cell Tumor

   phase 2 · small molecule · terminated

   1 trial →

3. pazopanib (GW786034)

   GlaxoSmithKline

   Neoplasms, Uterine Cervix

   phase 2 · small molecule · completed

   1 trial →

4. pazopanib (GW786034) 400 mg

   GlaxoSmithKline

   Neoplasms, Breast

   phase 2 · small molecule · completed

   1 trial →

5. pegcrisantaspase

   Jazz Pharmaceuticals Ireland Limited

   Acute Lymphoblastic Leukemia

   phase 2 · small molecule · terminated

   1 trial →

6. pembrolizumab

   Hospital Authority, Hong Kong

   Locally Recurrent Cancer

   phase 2 · small molecule · active

   1 trial →

7. pembrolizumab

   The University of Hong Kong

   T-Cell Lymphoma

   phase 2 · small molecule · active

   1 trial →

8. pembrolizumab

   The First People's Hospital of Lianyungang

   Advanced Non-squamous Non-small-cell Lung Cancer

   phase 2 · small molecule · active

   1 trial →

9. pemetrexed

   United Therapeutics Europe Ltd

   Lung Cancer

   phase 2 · small molecule · completed

   1 trial →

10. pepinemab + pembrolizumab

    VACCINEX, INC.

    Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)

    phase 2 · small molecule · completed

    1 trial →

11. pharmorubicin or pirarubicin

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

12. ponatinib - Phase 1

    Takeda

    Chronic Myeloid Leukemia (CML)

    phase 2 · small molecule · completed

    1 trial →

13. pyrotinib and trastuzumab in combinition with neoadjuvant chemotherapy

    The First People's Hospital of Lianyungang

    HER2-positive Breast Cancer

    phase 2 · small molecule · active

    1 trial →

14. radiation therapy

    Children's Hospital of Fudan University

    Brain Tumor

    phase 2 · other · completed

    1 trial →

15. raltitrexed combined with apatinib

    Chinese PLA General Hospital

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

16. recombinant human Angiostatin protein

    CASI Pharmaceuticals

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · completed

    1 trial →

17. recombinant human endostatin

    Peking University Third Hospital

    Melanoma

    phase 2 · small molecule · active

    1 trial →

18. remicade (anti tumor necrosis factor inhibitor)

    Hospital Authority, Hong Kong

    Takayasu's Arteritis

    phase 2 · small molecule · active

    1 trial →

19. rezatapopt

    PMV Pharmaceuticals

    Advanced Solid Tumor

    phase 2 · small molecule · active

    1 trial →

20. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 · mab · completed

    1 trial →

21. self-expandable 125I radioactive seeds-loaded-stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cholangiocellular Carcinoma

    phase 2 · other · completed

    1 trial →

22. silevertinib (BDTX-1535) monotherapy

    Blackmores Limited

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

23. sintilimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

24. sintilimab

    The First People's Hospital of Lianyungang

    Colorectal Neoplasms

    phase 2 · small molecule · active

    1 trial →

25. sintiliman plus LDRT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

26. ssCART-19

    The First People's Hospital of Lianyungang

    Relapsed or Refractory Acute Lymphoblastic Leukemia

    phase 2 · mab · active

    1 trial →

27. ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia, Adult B-Cell

    phase 2 · mab · active

    1 trial →

28. sunitinib added to FOLFIRI

    BRIGHT MINDS BIOSCIENCES INC.

    Metastatic Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

29. surufatinib + fulvestrant + chidamide

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

30. temozolomide

    Universal Integrated

    Cancer

    phase 2 · small molecule · completed

    1 trial →

31. temozolomide

    Children's Hospital of Fudan University

    Brain and Central Nervous System Tumors

    phase 2 · small molecule · completed

    1 trial →

32. the standard "3+7" regimen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Newly Diagnosed Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · active

    1 trial →

33. therapeutic autologous dendritic cells

    LISATA THERAPEUTICS, INC.

    Melanoma (Skin)

    phase 2 · mab · completed

    1 trial →

34. tisotumab vedotin

    Genmab A/S

    Solid Tumor

    phase 2 · small molecule · completed

    1 trial →

35. toripalimab

    The First People's Hospital of Lianyungang

    Malignant Melanoma

    phase 2 · small molecule · active

    1 trial →

36. trifluridine/tipiracil combined with fufuquitinib

    The First People's Hospital of Lianyungang

    Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

37. troxacitabine

    Takeda

    Leukemia

    phase 2 · small molecule · completed

    1 trial →

38. vidutolimod

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

39. vilastobart (XTX101)

    Xilio Therapeutics

    Advanced Solid Tumor

    phase 2 · small molecule · active

    1 trial →

40. vinflunine

    Bristol-Myers Squibb

    Transitional Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

41. vistusertib (AZD2014)

    Samsung Bioepis NL B.V.

    Small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

42. vitamin C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · completed

    1 trial →

43. vitamin C

    CNS Pharmaceuticals

    Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

44. volrustomig, Monalizumab

    Pari Pharma GmbH

    cancerology

    phase 2 · small molecule · active

    1 trial →

45. ​​D798VC00001​

    AstraZeneca AB

    ​​Colorectal cancer​

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions